Companies: 10,795·Total market cap: $144.5T
Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

ARWRNASDAQHealthcare● Active
$73.86
+$0.77(+1.05%)
Market Cap$10.4B
P/E Ratio
52W High$82.26
52W Low$14.3
Overview

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ARWR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.14arwr eps ttm · arwr earnings per shareEarnings history
PE Ratio (TTM)arwr pe ratio ttm · arwr price to earningsPE Ratio deep dive
Revenue (TTM)$622.0Marwr revenue ttm · arwr annual revenueFull revenue history
Dividend YieldNo Dividenddoes arwr pay dividends · arwr dividend yieldDividend history
Shares Outstanding133.8Marwr shares outstanding · arwr floatShares outstanding history
Next EarningsAug 6, 2026Est.arwr earnings date · arwr next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$829.4M▲ +23258.15% YoY
202320242025
arrowhead pharmaceuticals, inc. revenue · arwr revenue 2025
FY 2025Net Income-$1.6M▲ +99.73% YoY
202320242025
arrowhead pharmaceuticals, inc. net income · arwr profit 2025
FY 2025EPS$-0.01▲ +99.76% YoY
202320242025
arwr eps · arrowhead pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $622.0MNet Income: -$300.9MEPS: $-2.14View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy20 analystsis arwr a buy · arwr analyst rating
Strong Buy
0
Buy
15
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$73.86Current
$83.56Avg Target13.13% upside
$110.00High
arwr price target · arwr 12 month forecast

Total: 20 · Buy rate: 75.0%

The ARWR analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $83.56, representing +13.13% upside from the current price of $73.86.

Stock Performance

Full History
1D-2.75%
1W+2.38%
1M+0.55%
3M+22.18%
YTD+10.09%
1Y+341.10%
5Y-9.87%

About Arrowhead Pharmaceuticals, Inc.

CEOChristopher R. Anzalone
IPO DateDec 16, 1993
Employees609
CountryUS

Arrowhead Pharmaceuticals, Inc. founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challeng…

what is arrowhead pharmaceuticals, inc. · arwr stock overview · arrowhead pharmaceuticals, inc. company profile · who is arrowhead pharmaceuticals, inc. ceo · arwr NASDAQ · arrowhead pharmaceuticals, inc. headquarters · arrowhead pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Arrowhead Pharmaceuticals, Inc. (ARWR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 16, 1993. As of the latest trading session, ARWR stock price is $73.86, with a market capitalization of $10.4B. The stock has returned +341.10% over the past 12 months and +10.09% year-to-date.

According to 20 Wall Street analysts, the consensus rating for Arrowhead Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $83.56. In fiscal year 2025, Arrowhead Pharmaceuticals, Inc. reported revenue of $829.4M and net income of -$1.6M. For detailed data — including Arrowhead Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Arrowhead Pharmaceuticals, Inc. (ARWR) stock price is $73.86. The stock is traded on NASDAQ under the ticker symbol ARWR. The 52-week range is $14.30 – $82.26.

ARWR stock priceARWR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice